Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) for Research Applications

What This Product Solves

Angiotensin II, a potent endogenous octapeptide (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe), is a key tool compound for in vitro and in vivo research targeting cardiovascular mechanisms. Its robust, well-characterized action as a vasopressor and G protein-coupled receptor (GPCR) agonist underpins its central role in vascular smooth muscle cell hypertrophy research, hypertension mechanism studies, and cardiovascular remodeling investigation. Experimental workflows often deploy Angiotensin II to induce reproducible signaling events, model disease phenotypes, and probe receptor-mediated cascades relevant to vascular injury and inflammation. For researchers requiring validated, high-purity peptide for controlled stimulation of angiotensin receptors, Angiotensin II (SKU A1042) offers a reliable solution as detailed in the product dossier.

For further discussion of atomic actions and workflow benchmarks, see the internal article Angiotensin II: Potent Vasopressor and GPCR Agonist for V..., which contextualizes this compound within vascular modeling and hypertrophy studies. Researchers seeking scenario-driven assay guidance may also consult Angiotensin II (SKU A1042): Robust Solutions for Vascular... for protocol-focused insights.

Protocol Parameters

• Cell culture stimulation | 100 nM for 4 hours | Applicable to NADH/NADPH oxidase activity assays in cultured cells | Supports controlled activation of intracellular signaling pathways in vitro | workflow recommendation
• Rodent in vivo infusion | 500–1000 ng/min/kg via subcutaneous minipump, up to 28 days | Applied in abdominal aortic aneurysm model and cardiovascular remodeling investigation | Enables chronic, consistent dosing to induce vascular pathology | workflow recommendation
• Stock solution preparation | >10 mM in sterile water, ≥234.6 mg/mL in DMSO, ≥76.6 mg/mL in water | Required for batch consistency and solubility in experimental settings | Ensures maximal solubility and aliquot stability for repeated use | product dossier
• Storage | Aliquoted at -80°C for months; desiccated at -20°C for dry peptide | Appropriate for long-term peptide integrity pre-use | Prevents degradation and supports reproducibility | product dossier

Workflow Setup and QC Checklist

• Peptide Handling: Always equilibrate vials to room temperature before opening to avoid condensation. Use sterile technique and low-protein-binding tubes for reconstitution.
• Stock Solution Preparation: Dissolve Angiotensin II in sterile water or DMSO according to solubility guidelines. For most cell-based protocols, prepare >10 mM stocks in sterile water, aliquot, and store at -80°C. Avoid freeze-thaw cycles.
• Working Dilutions: Prepare fresh working solutions immediately before use, diluting stocks in pre-warmed assay buffer or culture medium to minimize peptide loss from adsorption.
• Administration in Animal Models: For minipump infusion, ensure pump calibration and sterility. Use appropriate carrier buffers and monitor for precipitation over time.
• Assay Controls: Include vehicle and non-peptide controls to confirm specificity of observed effects.
• QC Verification: Confirm peptide identity via mass spectrometry or HPLC profile, if available, especially for critical or long-term studies.

Common Failure Modes and Fixes

• Peptide Precipitation: Angiotensin II is insoluble in ethanol and may precipitate in some aqueous buffers. Always check solubility limits and avoid incompatible solvents; if precipitation occurs, gently warm and vortex, or switch to a recommended solvent (water or DMSO).
• Loss of Activity After Storage: Extended storage of solution stocks at temperatures above -80°C or repeated freeze-thaw cycles can degrade peptide activity. Prepare aliquots for single use, and discard unused portions after thawing.
• Batch-to-Batch Variability: Minimize variability by using aliquots from a single lot for a given study. Document lot numbers and storage durations for traceability.
• Non-specific Effects in Cell Culture: High concentrations or prolonged exposure may induce off-target effects. Titrate peptide concentrations and treatment durations for each experimental setup.

Scope and Limitations

This Angiotensin II product is intended strictly for scientific research and not for diagnostic or medical applications. Its validated uses include hypertension mechanism study, cardiovascular remodeling investigation, and modeling of vascular smooth muscle cell hypertrophy or abdominal aortic aneurysm in cell and animal models. It is not recommended for clinical trials, patient diagnostics, or therapeutic use. Protocols should be tailored to the specific receptor and cell context, as receptor subtype expression and tissue responsiveness may affect outcomes. Researchers must ensure compatibility with their assay system and verify peptide integrity prior to critical experiments. Workflow recommendations are based on reported assay conditions and may require optimization for novel applications.

Conclusion

Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) is a core reagent for dissecting angiotensin receptor signaling, modeling disease processes, and studying vascular function in controlled experimental systems. Reliable reconstitution, storage, and delivery protocols—grounded in the product dossier—are essential for reproducibility in hypertension, vascular remodeling, and abdominal aortic aneurysm research. For additional application guidance, the APExBIO Angiotensin II page provides further technical detail. Always align usage with validated protocols and document all handling steps to support rigorous data interpretation.